Logo image of SCL

STEPAN CO (SCL) Stock Fundamental Analysis

NYSE:SCL - New York Stock Exchange, Inc. - US8585861003 - Common Stock - Currency: USD

54.29  -1.22 (-2.2%)

After market: 54.29 0 (0%)

Fundamental Rating

4

Taking everything into account, SCL scores 4 out of 10 in our fundamental rating. SCL was compared to 85 industry peers in the Chemicals industry. While SCL is still in line with the averages on profitability rating, there are concerns on its financial health. SCL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SCL had positive earnings in the past year.
In the past year SCL had a positive cash flow from operations.
In the past 5 years SCL has always been profitable.
In the past 5 years SCL always reported a positive cash flow from operatings.
SCL Yearly Net Income VS EBIT VS OCF VS FCFSCL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of SCL (2.35%) is better than 61.18% of its industry peers.
SCL has a Return On Equity (4.68%) which is comparable to the rest of the industry.
SCL has a Return On Invested Capital (3.96%) which is in line with its industry peers.
SCL had an Average Return On Invested Capital over the past 3 years of 5.63%. This is in line with the industry average of 6.86%.
Industry RankSector Rank
ROA 2.35%
ROE 4.68%
ROIC 3.96%
ROA(3y)3.31%
ROA(5y)4.77%
ROE(3y)6.74%
ROE(5y)9.18%
ROIC(3y)5.63%
ROIC(5y)7.38%
SCL Yearly ROA, ROE, ROICSCL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

Looking at the Profit Margin, with a value of 2.53%, SCL is in line with its industry, outperforming 56.47% of the companies in the same industry.
SCL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 3.54%, SCL is doing worse than 67.06% of the companies in the same industry.
In the last couple of years the Operating Margin of SCL has declined.
SCL's Gross Margin of 12.48% is on the low side compared to the rest of the industry. SCL is outperformed by 78.82% of its industry peers.
SCL's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.54%
PM (TTM) 2.53%
GM 12.48%
OM growth 3Y-24.2%
OM growth 5Y-14.3%
PM growth 3Y-26.73%
PM growth 5Y-16.07%
GM growth 3Y-9.55%
GM growth 5Y-7.34%
SCL Yearly Profit, Operating, Gross MarginsSCL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SCL is destroying value.
The number of shares outstanding for SCL has been increased compared to 1 year ago.
Compared to 5 years ago, SCL has about the same amount of shares outstanding.
SCL has a better debt/assets ratio than last year.
SCL Yearly Shares OutstandingSCL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
SCL Yearly Total Debt VS Total AssetsSCL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.49 indicates that SCL is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SCL (2.49) is better than 71.76% of its industry peers.
The Debt to FCF ratio of SCL is 317.88, which is on the high side as it means it would take SCL, 317.88 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 317.88, SCL perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
SCL has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of SCL (0.28) is better than 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 317.88
Altman-Z 2.49
ROIC/WACC0.46
WACC8.6%
SCL Yearly LT Debt VS Equity VS FCFSCL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

SCL has a Current Ratio of 1.21. This is a normal value and indicates that SCL is financially healthy and should not expect problems in meeting its short term obligations.
SCL's Current ratio of 1.21 is on the low side compared to the rest of the industry. SCL is outperformed by 78.82% of its industry peers.
A Quick Ratio of 0.79 indicates that SCL may have some problems paying its short term obligations.
SCL has a worse Quick ratio (0.79) than 77.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 0.79
SCL Yearly Current Assets VS Current LiabilitesSCL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.15% over the past year.
The earnings per share for SCL have been decreasing by -15.51% on average. This is quite bad
Looking at the last year, SCL shows a decrease in Revenue. The Revenue has decreased by -0.16% in the last year.
SCL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.24% yearly.
EPS 1Y (TTM)12.15%
EPS 3Y-29.09%
EPS 5Y-15.51%
EPS Q2Q%31.25%
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y-2.41%
Revenue growth 5Y3.24%
Sales Q2Q%7.59%

3.2 Future

The Earnings Per Share is expected to grow by 35.34% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.64% on average over the next years.
EPS Next Y44.15%
EPS Next 2Y35.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.56%
Revenue Next 2Y7.46%
Revenue Next 3Y8.56%
Revenue Next 5Y6.64%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SCL Yearly Revenue VS EstimatesSCL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
SCL Yearly EPS VS EstimatesSCL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.62, SCL is valued on the expensive side.
SCL's Price/Earnings is on the same level as the industry average.
SCL's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 26.25.
Based on the Price/Forward Earnings ratio of 13.47, the valuation of SCL can be described as correct.
SCL's Price/Forward Earnings ratio is in line with the industry average.
SCL's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.15.
Industry RankSector Rank
PE 22.62
Fwd PE 13.47
SCL Price Earnings VS Forward Price EarningsSCL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SCL is valued a bit cheaper than 61.18% of the companies in the same industry.
SCL's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 591.06
EV/EBITDA 9.24
SCL Per share dataSCL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

SCL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SCL's earnings are expected to grow with 35.34% in the coming years.
PEG (NY)0.51
PEG (5Y)N/A
EPS Next 2Y35.34%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

SCL has a Yearly Dividend Yield of 2.77%.
Compared to an average industry Dividend Yield of 3.75, SCL pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.38, SCL has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.77%

5.2 History

On average, the dividend of SCL grows each year by 8.06%, which is quite nice.
SCL has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of SCL decreased recently.
Dividend Growth(5Y)8.06%
Div Incr Years1
Div Non Decr Years1
SCL Yearly Dividends per shareSCL Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

SCL pays out 60.89% of its income as dividend. This is not a sustainable payout ratio.
The dividend of SCL is growing, but earnings are growing more, so the dividend growth is sustainable.
DP60.89%
EPS Next 2Y35.34%
EPS Next 3YN/A
SCL Yearly Income VS Free CF VS DividendSCL Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
SCL Dividend Payout.SCL Dividend Payout, showing the Payout Ratio.SCL Dividend Payout.PayoutRetained Earnings

STEPAN CO

NYSE:SCL (5/30/2025, 8:04:00 PM)

After market: 54.29 0 (0%)

54.29

-1.22 (-2.2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)07-29 2025-07-29/bmo
Inst Owners86.22%
Inst Owner Change0.01%
Ins Owners4.64%
Ins Owner Change2.36%
Market Cap1.23B
Analysts76.67
Price Target86.7 (59.7%)
Short Float %1.71%
Short Ratio2.4
Dividend
Industry RankSector Rank
Dividend Yield 2.77%
Yearly Dividend1.51
Dividend Growth(5Y)8.06%
DP60.89%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-30 2025-05-30 (0.385)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-17.21%
Min EPS beat(2)-65.06%
Max EPS beat(2)30.63%
EPS beat(4)2
Avg EPS beat(4)-4.44%
Min EPS beat(4)-65.06%
Max EPS beat(4)56.09%
EPS beat(8)3
Avg EPS beat(8)-2.6%
EPS beat(12)6
Avg EPS beat(12)0.55%
EPS beat(16)8
Avg EPS beat(16)2.63%
Revenue beat(2)1
Avg Revenue beat(2)2.45%
Min Revenue beat(2)-0.36%
Max Revenue beat(2)5.27%
Revenue beat(4)1
Avg Revenue beat(4)-2.32%
Min Revenue beat(4)-7.59%
Max Revenue beat(4)5.27%
Revenue beat(8)1
Avg Revenue beat(8)-4.75%
Revenue beat(12)4
Avg Revenue beat(12)-2.02%
Revenue beat(16)8
Avg Revenue beat(16)0.59%
PT rev (1m)0%
PT rev (3m)-5.56%
EPS NQ rev (1m)25.83%
EPS NQ rev (3m)-14.08%
EPS NY rev (1m)-1.36%
EPS NY rev (3m)-14.29%
Revenue NQ rev (1m)2.36%
Revenue NQ rev (3m)2.53%
Revenue NY rev (1m)2.76%
Revenue NY rev (3m)1.66%
Valuation
Industry RankSector Rank
PE 22.62
Fwd PE 13.47
P/S 0.55
P/FCF 591.06
P/OCF 9.62
P/B 1.02
P/tB 1.15
EV/EBITDA 9.24
EPS(TTM)2.4
EY4.42%
EPS(NY)4.03
Fwd EY7.42%
FCF(TTM)0.09
FCFY0.17%
OCF(TTM)5.64
OCFY10.4%
SpS98.41
BVpS53.17
TBVpS47.15
PEG (NY)0.51
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.35%
ROE 4.68%
ROCE 4.76%
ROIC 3.96%
ROICexc 4.24%
ROICexgc 4.65%
OM 3.54%
PM (TTM) 2.53%
GM 12.48%
FCFM 0.09%
ROA(3y)3.31%
ROA(5y)4.77%
ROE(3y)6.74%
ROE(5y)9.18%
ROIC(3y)5.63%
ROIC(5y)7.38%
ROICexc(3y)6.06%
ROICexc(5y)8.61%
ROICexgc(3y)6.68%
ROICexgc(5y)9.41%
ROCE(3y)6.76%
ROCE(5y)8.87%
ROICexcg growth 3Y-28.84%
ROICexcg growth 5Y-19.33%
ROICexc growth 3Y-28.18%
ROICexc growth 5Y-20.06%
OM growth 3Y-24.2%
OM growth 5Y-14.3%
PM growth 3Y-26.73%
PM growth 5Y-16.07%
GM growth 3Y-9.55%
GM growth 5Y-7.34%
F-Score6
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 317.88
Debt/EBITDA 1.72
Cap/Depr 110.1%
Cap/Sales 5.64%
Interest Coverage 2.68
Cash Conversion 66.22%
Profit Quality 3.69%
Current Ratio 1.21
Quick Ratio 0.79
Altman-Z 2.49
F-Score6
WACC8.6%
ROIC/WACC0.46
Cap/Depr(3y)225.06%
Cap/Depr(5y)209.82%
Cap/Sales(3y)9.23%
Cap/Sales(5y)8.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.15%
EPS 3Y-29.09%
EPS 5Y-15.51%
EPS Q2Q%31.25%
EPS Next Y44.15%
EPS Next 2Y35.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.16%
Revenue growth 3Y-2.41%
Revenue growth 5Y3.24%
Sales Q2Q%7.59%
Revenue Next Year8.56%
Revenue Next 2Y7.46%
Revenue Next 3Y8.56%
Revenue Next 5Y6.64%
EBIT growth 1Y9.96%
EBIT growth 3Y-26.03%
EBIT growth 5Y-11.52%
EBIT Next Year223.94%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y100.93%
FCF growth 3YN/A
FCF growth 5Y-19.02%
OCF growth 1Y16.28%
OCF growth 3Y30.97%
OCF growth 5Y-5.79%